Local is purulent-septic complications of vascular accesses and angiogenic sepsis in patients on a program hemodialysis


Cite item

Full Text

Abstract

Features of a clinical course of purulent-septic complications (аngiogenic sepsis and infection of the area of surgical intervention) vascular admissions in patients on a program hemodialysis, the microbiological spectrum and its dynamics against lead treatment was investigated. Were defi ned prognostic criteria of development of the developed differentiated tactics of antibiotic prophylaxis. Effi ciency of various variants of antibacterial therapy is estimated and medical tactics at occurrence of is purulent-septic complications was optimised.

About the authors

Первый Московский государственный медицинский университет им. И.М.Сеченова

Author for correspondence.
Email: docmax2002@mail.ru
д.м.н., профессор кафедры общей хирургии Первого Московского государственного медицинского университета им. И.М.Сеченова

Госпиталь ветеранов войн №2, г. Москва

Email: docmax2002@mail.ru
д.м.н., заве- дующий отделением сосудистой хирургии го- спиталя ветеранов войн №2 г. Москвы

Первый Московский государственный медицинский университет им. И.М.Сеченова

Email: docmax2002@mail.ru
к.м.н., ассистент кафедры общей хирургии Первого Московского государственного медицинского университета им. И.М.Сеченова

Госпиталь ветеранов войн №2, г. Москва

Email: docmax2002@mail.ru
к.м.н., врач от- деления сосудистой хирургии госпиталя ветеранов войн №2 г. Москвы

Госпиталь ветеранов войн №2, г. Москва

Email: docmax2002@mail.ru
врач отделения со- судистой хирургии госпиталя ветеранов войн №2 г. Москвы

Госпиталь ветеранов войн №2, г. Москва

Email: docmax2002@mail.ru
врач отделения сосу- дистой хирургии госпиталя ветеранов войн №2 г. Москвы

References

  1. Bikbov B.T., Tomilina N.A. Sostoianie zamestitel'noi
  2. terapii u bol'nykh s khronicheskoi pochechnoi nedosta-
  3. tochnost'iu v Rossiiskoi Federatsii v 1998-2007 gg.
  4. (Analiticheskii otchet po dannym Rossiiskogo regi-
  5. stra zamestitel'noi pochechnoi terapii). Nefrologiia i
  6. gemodializ 2009; 11; 3: 144-233.
  7. Briskin B.S., Khachatrian N.N., Ionov S.A., Khmelevskii
  8. S.V. Antibiotikoprofilaktika v abdominal'noi khi-
  9. rurgii. Consilium Medicum. 2003; 5; 4: 253-255.
  10. Ganeev T.S., Ganeeva A.T. Angiokhirurgicheskoe obespe-
  11. chenie bol'nykh na gemodialize. Nefrologiia 2003; 7:
  12. -117.
  13. Daugirdas Dzh.T., Bleik P.Dzh., Ing T.S. Rukovodstvo
  14. po dializu. Per. s ang. pod red. A.Iu. Denisova i V.Iu.
  15. Shilo.- Tret'e izdanie. M. Tsentr dializa. Tver'. OOO
  16. Izdatel'stvo «Triada» 2003; 744.
  17. Dundarov Z.A. Angiogennyi sepsis pri kateterizatsii
  18. magistral'nykh ven. Zdravookhranenie 2001; 10: 2-3.
  19. Zatevakhin I.I., Komrakov V.E. Infektsiia v sosudistoi
  20. khirurgii. M. «MIK» 1998; 208.
  21. Klinicheskie prakticheskie rekomendatsii po sosu-
  22. distomu dostupu (NKF-DOQI). Pod red. G. Beathard,
  23. D. Brouwer, E. Etheredge, M. Hartigan, M. Levine, R.
  24. McCann, R. Sherman, S. Trerotola. Per. s angl. S.V. La-
  25. shutinym. Tver': Gubernskaia meditsina 2000; 192.
  26. Lytkin M.I., Shikhverdiev N.N. Angiogennyi sepsis.
  27. Vestn. khirurgii 1983; 130; 4: 135-139.
  28. Moisiuk Ia.G., Beliaev A.Iu. Postoiannyi sosudistyi do-
  29. stup. Tver'. Triada 2004; 152.
  30. Filiptsev P.Ia. Kompleksnaia terapiia sepsisa u bol'nykh
  31. terminal'noi KhPN. Metod. rekomendatsii. M. 1987; 13.
  32. Abbott K.C., Agodoa L.Y. Etiology of bacterial septicemia in
  33. chronic dialysis patients in the United States. Clin Nephrol
  34. ; 56:124-31.
  35. Arduino M.J., Tokars J.I. Why is an infection control
  36. program needed in the hemodialysis setting? Nephrol News
  37. Issues 2005; 19(7):44, 46-9.
  38. Bone R.C., Balk R.A., Cerra F.B. et al. Defi nitions for sepsis
  39. and organ failure and guidelines for the use of innovative
  40. therapies in sepsis: the ACCP. SCCM Consensus Conference
  41. Committee. American College of Chest Physicians/Society
  42. of Critical Care Medicine. Chest 1992; 101: 1644-1655.
  43. Knaus W.A., Wagner D.P., Draper E.A. et al. The APACHE
  44. III prognostic System. Risk prediction of hospital mortality
  45. for critically ill hospitalized adults. Chest. 1991; 100; 6:
  46. -1636.
  47. Minga T.E., Flanagan K., Allon M. Die klinischen Folgen von
  48. infi zierten AV-Shunt-Prothesen bei Hämodialysepatienten.
  49. Aktuelle Nephrologie 2002; 35 (2): 111-112.
  50. Ronald K., Woods R.K., Dellinger E.P. Current guidelines
  51. for Antibiotic Prophylaxis of Surgical Wounds. American
  52. Academy of Family Physicians. 1998; 57 (6): 2731-2740.
  53. Ryan S.V., Calligaro K.D., McAffee-Bennett S. et al.
  54. Management of infected prosthetic dialysis arteriovenous
  55. grafts. J. Vasc. Surg. 2004;39: 73-78.
  56. Saxena A.K., Panhotra B.R. Haemodialysis catheter-related
  57. bloodstream infections: current treatment options and
  58. strategies for prevention. Swiss Med Weekly 2005; 135:127-
  60. Schild A.F., Perez E., Gillaspie E., Seaver C., Livingstone
  61. J., Thibonnier A. Arteriovenous fi stulae vs arteriovenous
  62. grafts: a retrospective review of 1700 consecutive vascular
  63. access cases. J. Vasc. Access 2008; 9: 231-235.
  64. US Renal Data System: USRDS 2007 Annual Data Report.
  65. The National Institutes of Health, National Institute of
  66. Diabetes and Digestive and Kidney Diseases, Bethesda,
  67. MD 2007.
  68. Zibari G.B., Gadallah M.R., Landreneau M. et al.
  69. Preoperative vancomycin prophylaxis decreases incidence
  70. of postoperative hemodialysis vascular access infections.
  71. Am J Kidney Dis 1997; 30: 343-348.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 ., ., ., ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies